Wall Street Experts
ver. ZuMIgo(08/25)
Sana Biotechnology, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 0
EBIT TTM (mln): -308
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
Rok finansowy |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Przychód Δ r/r |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
Marża brutto |
-inf% |
-inf% |
-inf% |
-inf% |
-inf% |
-inf% |
0.0% |
EBIT (mln) |
-8 |
-141 |
-286 |
-357 |
-273 |
-326 |
-273 |
EBIT Δ r/r |
0.0% |
1617.0% |
102.7% |
24.7% |
-23.6% |
19.5% |
-16.3% |
EBIT (%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
nan |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
-16 |
0 |
0 |
EBITDA (mln) |
-13 |
-139 |
-286 |
-357 |
-273 |
-295 |
-273 |
EBITDA(%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
nan |
Podatek (mln) |
0 |
-8 |
-7 |
-12 |
-3 |
0 |
0 |
Zysk Netto (mln) |
-13 |
-131 |
-279 |
-344 |
-266 |
-283 |
-267 |
Zysk netto Δ r/r |
0.0% |
887.2% |
113.1% |
23.5% |
-22.6% |
6.3% |
-5.8% |
Zysk netto (%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
nan |
EPS |
-0.0707 |
-0.7 |
-1.49 |
-2.07 |
-1.41 |
-1.46 |
-1.16 |
EPS (rozwodnione) |
-0.0707 |
-0.7 |
-1.49 |
-2.07 |
-1.41 |
-1.46 |
-1.16 |
Ilośc akcji (mln) |
187 |
187 |
188 |
166 |
188 |
195 |
231 |
Ważona ilośc akcji (mln) |
187 |
187 |
188 |
166 |
188 |
195 |
231 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |